Evidence map›Paper›PMID 21295809›Full record

ArticleSurgery2011

Effects of glucagon-like peptide 1 on glycemia control and its metabolic consequence after severe thermal injury--studies in an animal model.

Chuan-an Shen, Shawn Fagan, Alan J Fischman, Edward E Carter, Jia-Ke Chai, Xiao-Ming Lu, Yong-Ming Yu, Ronald G Tompkins

Abstract read
In one paragraph

Article in Surgery, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Alcohol Intoxication and the Postburn Gastrointestinal Hormonal Response.Journal of burn care & research : official publication of the American Burn Association · 2019
    Article
  6. Review
  7. Article
  8. Proinflammatory switch from Gαs to Gαi signaling by Glucagon-like peptide-1 receptor in murine splenic monocyte following burn injury.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Article
  9. Article
  10. The extracellular matrix protein matrilin-2 induces post-burn inflammatory responses as an endogenous danger signal.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Chuan-an ShenBurn Unit, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Shawn Fagan
Alan J Fischman
Edward E Carter
Jia-Ke Chai
Xiao-Ming Lu
Yong-Ming Yu
Ronald G Tompkins
Massachusetts General Hospital · USFirst Affiliated Hospital of Chinese PLA General Hospital · CN

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
WOUND HEALINGP50GM021700 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI TOMPKINS, RONALD GARY · 1985 to 2017
$27.2M
TRAINING IN BURNS AND TRAUMA RESEARCHT32GM007035 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI TOMPKINS, RONALD GARY · 1985 to 2014
$3.5M
NIDDK NIH HHS P30 DK040561NIGMS NIH HHS 2P50 GM 021700NIGMS NIH HHS GM 07035NIGMS NIH HHS P50 GM021700NIGMS NIH HHS T32 GM007035
6 · The paper itself

Abstract

backgroundHyperglycemia with insulin resistance is commonly seen in severely burned patients and tight glycemia control with insulin may be beneficial in this condition. The most potent insulinotropic hormone, glucagon-like peptide 1 (GLP-1), stimulates insulin secretion in a glucose-dependent manner. Because infusion of GLP-1 never reduces glucose levels to below ∼70 mg/dL, the risk of hypoglycemia by using insulin is reduced. In this study we investigated the metabolic effects of GLP-1 infusion after burn injury in an animal model.

methodsMale CD rats were divided in 3 groups: burn injury with saline, burn injury with GLP-1 treatment, and sham burn (SB). Burn injury was full thickness 40% total body surface area. The burn injury with GLP-1 treatment group received GLP-1 infusion via osmotic pump. Fasting blood glucose, plasma insulin, and plasma GLP-1 levels were measured during intraperitoneal glucose tolerance tests. Expressions of caspase 3 and bcl-2 were evaluated in pancreatic islets. In a subset of animals, protein metabolism and total energy expenditure were measured.

resultsFasting GLP-1 was reduced in burn injury with saline compared to SB or burn injury with GLP-1 treatment. Burn injury with GLP-1 treatment showed reduced fasting blood glucose, improved intraperitoneal glucose tolerance test results, with increased plasma insulin and GLP-1 responses to glucose. GLP-1 reduced protein breakdown and total energy expenditure in burn injury with GLP-1 treatment versus burn injury with saline, with improved protein balance. Increased expression of caspase 3 and decreased expression of bcl-2 in islet cells by burn injury were ameliorated by GLP-1.

conclusionBurn injury reduced plasma GLP-1 in association with insulin resistance. GLP-1 infusion improved glucose tolerance and showed anabolic effects on protein metabolism and reduced total energy expenditure after burn injury, possibly via insulinotropic and non insulinotropic mechanisms.

Indexed as

AnimalsBlood GlucoseBurnsCaspase 3Energy MetabolismGlucagon-Like Peptide 1HyperglycemiaIncretinsInsulinInsulin ResistanceIslets of LangerhansMaleModels, AnimalProto-Oncogene Proteins c-bcl-2RatsRats, Inbred StrainsBlood GlucoseCaspase 3Glucagon-Like Peptide 1IncretinsInsulinProto-Oncogene Proteins c-bcl-2

Identifiers

PMID21295809
PMCPMC3079016
OpenAlexW2082858358

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.